Circulating plasmacytoid dendritic cells in acutely infected patients with hepatitis C virus genotype 4 are normal in number and phenotype

Journal of Infectious Diseases

Volumn 202, Issue 11, 2010, Pages 1671-1675

  Mansour, Hala ^a   Laird, Melissa E ^d   Saleh, Rasha ^b   Casrouge, Armanda ^d   Eldin, Noha Sharaf ^b   El Kafrawy, Sherif ^a   Hamdy, Maha ^b   Decalf, Jérémie ^d   Rosenberg, Brad R ^f   Fontanet, Arnaud ^d   Abdel Hamid, Mohammed ^a,c   Mohamed, Mostafa K ^a,b   Albert, Matthew L ^d,e   Rafik, Mona ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Minia University   (Egypt)

^d INSTITUT PASTEUR   (France)

^e INSERM   (France)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; BETA1 INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MYXOVIRUS RESISTANCE PROTEIN A; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST;

ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

DENDRITIC CELLS; EGYPT; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TOLL-LIKE RECEPTORS;

EID: 78649545869     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/656777     Document Type: Article

References (15)

1. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355:887-891.
2. Maheshwari A, Ray S and Thuluvath PJ. Acute hepatitis C. Lancet 2008; 372:321-332.
3. Bigger CB, Brasky KM and Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001; 75:7059-7066.
4. Su AI, Pezacki JP, Wodicka L, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 2002; 99:15669-15674.
5. El Gaafary MM, Rekacewicz C, Abdel-Rahman AG, et al. Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol 2005; 76:520-525. (Pubitemid 40943262)
6. Ito T, Kanzler H, Duramad O, Cao W and Liu YJ. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 2006; 107:2423-2431.
7. Decalf J, Fernandes S, Longman R, et al. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med 2007; 204:2423-2437.
8. Mihm S, Frese M, Meier V, et al. Interferon type I gene expression in chronic hepatitis C. Lab Invest 2004; 84:1148-1159.
9. Foy E, Li K, Sumpter R Jr, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 2005; 102:2986-2991.
10. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005; 102:17717-17722.
11. Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437:1167-1172.
12. Foy E, Li K, Wang C, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003; 300:1145-1148.
13. Longman RS, Talal AH, Jacobson IM, Albert ML Rice CM. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 2004; 103:1026-1029.
14. Longman RS, Talal AH, Jacobson IM, Rice CM, Albert ML. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 2005; 192:497-503.
15. Shiina M, Rehermann B. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology 2008; 47:385-395. (Pubitemid 351280706)